Gene · 2091
Papers2,899
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,899
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cajal bodies: Evolutionarily conserved nuclear biomolecular condensates with properties unique to plants. | Plant Cell | 2023 | 37202374 | PubTator, text mining | PubMed |
| Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. | Cells | 2023 | 37190010 | PubTator, text mining | PubMed |
| On the Roles of the Nuclear Non-Coding RNA-Dependent Membrane-Less Organelles in the Cellular Stress Response. | Int J Mol Sci | 2023 | 37175815 | PubTator, text mining | PubMed |
| Description of Peripheral Blood Perfusion by Laser Speckle Contrast Analysis (LASCA) in 'Early' versus 'Clinically Overt' Systemic Sclerosis in Routine Clinics. | Diagnostics (Basel) | 2023 | 37174957 | PubTator, text mining | PubMed |
| Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis. | Aging Cell | 2023 | 37157887 | PubTator, text mining | PubMed |
| Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options. | J Clin Immunol | 2023 | 37156989 | PubTator, text mining | PubMed |
| Diagnostic Performance of Anti-Topoisomerase-I, Anti-Th/To Antibody and Anti-Fibrillarin Using Immunoblot Method in Systemic Sclerosis Related Interstitial Lung Disease Patients. | Open Access Rheumatol | 2023 | 37143703 | PubTator, text mining | PubMed |
| KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. | Adv Sci (Weinh) | 2023 | 37142882 | PubTator, text mining | PubMed |
| Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. | Cell Death Differ | 2023 | 37142656 | PubTator, text mining | PubMed |
| Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposure. | Environ Toxicol Pharmacol | 2023 | 37137421 | PubTator, text mining | PubMed |
| HMGXB4 Targets Sleeping Beauty Transposition to Germinal Stem Cells. | Int J Mol Sci | 2023 | 37108449 | PubTator, text mining | PubMed |
| Nucleolar Protein 56 Deficiency in Zebrafish Leads to Developmental Abnormalities and Anemia via p53 and JAK2-STAT3 Signaling. | Biology (Basel) | 2023 | 37106740 | PubTator, text mining | PubMed |
| RNA-mediated demixing transition of low-density condensates. | Nat Commun | 2023 | 37105967 | PubTator, text mining | PubMed |
| The Importance of Being RNA-est: considering RNA-mediated ribosome plasticity. | RNA Biol | 2023 | 37098839 | PubTator, text mining | PubMed |
| Clinical and serological correlation of systemic sclerosis in Moroccan patients. | Rheumatol Adv Pract | 2023 | 37091295 | PubTator, text mining | PubMed |
| The Phytophthora nucleolar effector Pi23226 targets host ribosome biogenesis to induce necrotrophic cell death. | Plant Commun | 2023 | 37087572 | PubTator, text mining | PubMed |
| Motif conservation, stability, and host gene expression are the main drivers of snoRNA expression across vertebrates. | Genome Res | 2023 | 37072185 | PubTator, text mining | PubMed |
| The Proteins of mRNA Modification: Writers, Readers, and Erasers. | Annu Rev Biochem | 2023 | 37068770 | PubTator, text mining | PubMed |
| The essential roles of small non-coding RNAs and RNA modifications in normal and malignant hematopoiesis. | Front Mol Biosci | 2023 | 37065445 | PubTator, text mining | PubMed |
| Enhanced nuclear translation is associated with proliferation and progression across multiple cancers. | MedComm (2020) | 2023 | 37063610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2091/papers?page=15